Pronutria is transforming medicine with ProNutrein products, protein nutrients identified in the human diet with specific pharmacologic effects, for improving health and treating many critical health issues, including diabetes, obesity, muscle loss, and diseases with impaired nutrient absorption. ProNutreins are naturally occurring, orally consumed pure protein products that trigger specific pharmacologic effects through pure, precise and reproducible delivery of amino acids. Pronutria is the only company with access to a library containing over a billion protein nutrients and the tools to select them for specific indications and population segments. Pronutria offers an unprecedented platform with the ability to develop many first and best in class ProNutrein products as dietary supplements, medical foods and drugs.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
10/22/13 | $10,800,000 | Series A |
Flagship Ventures | undisclosed |